About the smallcase


  • SuperNormal Smallcap stocks which are in the accelerating and potentially explosive growth phase yet not fully identified by the market.
  • Strong fundamentals, growing businesses, getting entrenched and large TAM (Target addressable market).
  • Strategy capitalizes on mispricing using a superior valuation toolkit.



  • If you are an existing investor of Omniscience Capital on an AUM Fee model, please contact us before subscribing to this product.
  • LUMPSUM: To get maximum benefit from this investment, start with a lump sum of INR 2.5 Lakhs.
  • SIP: For a lower starting amount, do an SIP of INR 5K per month.
  • Holding Period: The minimum holding period should be preferably 5 years but at least 3 years.
  • To stay updated on our latest research, reports and investment strategies, you can follow us on our social media handles, viz., @OmniScienceCap and @OmniScience_IN Twitter handles, @OmniScience Capital and @OmniScience smallcase LinkedIn pages, @OmniScienceCapital page on Facebook and @OmniScienceCap handle on Instagram.


Download key points of this smallcase

Live Performance vs 

Current value of ₹ 100 invested once
at launch

Oct 27, 2020

would be
Omni SmallCap Supertrons
₹ 371.81
Equity Smallcap
₹ 212.12

Note: Live performance includes rebalances. It is a tool to communicate factual return information and should not be seen as advertisement or promotion.

Understand smallcase costs and returns

Understand smallcase costs and returns